OncoFusion Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

OncoFusion Therapeutics General Information

Description

Developer of oncology discovery therapeutics designed to treat cancers. The company's therapeutics focus on bromodomain inhibitors, ERG inhibitors, EZH-2-EED inhibitors, and MMSET/NSD 2 inhibitors, enabling doctors to treat genetically defined cancers.

Contact Information

Website
www.oncofusion.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 1600 Huron Parkway
  • 2nd Floor
  • Ann Arbor, MI 48109
  • United States
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Other Healthcare Services
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 1600 Huron Parkway
  • 2nd Floor
  • Ann Arbor, MI 48109
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoFusion Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business Completed Out of Business
2. Angel (individual) 01-Mar-2013 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2013 Completed Startup
To view OncoFusion Therapeutics’s complete valuation and funding history, request access »

OncoFusion Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncology discovery therapeutics designed to treat cancers. The company's therapeutics focus on bromodomain
Biotechnology
Ann Arbor, MI
5 As of 2018

Saint Louis, MO

Malvern, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoFusion Therapeutics Competitors (2)

One of OncoFusion Therapeutics’s 2 competitors is Euclises, a Venture Capital-Backed company based in Saint Louis, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Euclises Venture Capital-Backed Saint Louis, MO
Galera Therapeutics Formerly VC-backed Malvern, PA
You’re viewing 2 of 2 competitors. Get the full list »

OncoFusion Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoFusion Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Partnerships Venture Capital Minority
To view OncoFusion Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

OncoFusion Therapeutics FAQs

  • When was OncoFusion Therapeutics founded?

    OncoFusion Therapeutics was founded in 2012.

  • Where is OncoFusion Therapeutics headquartered?

    OncoFusion Therapeutics is headquartered in Ann Arbor, MI.

  • What is the size of OncoFusion Therapeutics?

    OncoFusion Therapeutics has 5 total employees.

  • What industry is OncoFusion Therapeutics in?

    OncoFusion Therapeutics’s primary industry is Biotechnology.

  • Is OncoFusion Therapeutics a private or public company?

    OncoFusion Therapeutics is a Private company.

  • What is OncoFusion Therapeutics’s current revenue?

    The current revenue for OncoFusion Therapeutics is .

  • How much funding has OncoFusion Therapeutics raised over time?

    OncoFusion Therapeutics has raised $525K.

  • Who are OncoFusion Therapeutics’s investors?

    Innovation Partnerships has invested in OncoFusion Therapeutics.

  • Who are OncoFusion Therapeutics’s competitors?

    Euclises and Galera Therapeutics are competitors of OncoFusion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »